- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Established, Profitable and Undervalued
Japanese Pharmaceuticals & Biotech Established, Profitable and Undervalued
UPDATED Aug 10, 2022
Over $1bn in market cap, profitable and undervalued based on cash flows.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 4568Daiichi Sankyo Company | JP¥3,632.00 | 6.6% | 59.9% | JP¥7.0t | JP¥4,250.00 | PE137.6x | E33.3% | 0.7% | ||
| 4519Chugai Pharmaceutical | JP¥3,784.00 | 2.4% | -7.6% | JP¥6.2t | JP¥4,617.50 | PE16x | E0.5% | 2.0% | ||
| 4502Takeda Pharmaceutical | JP¥3,782.00 | 1.7% | 3.7% | JP¥5.8t | JP¥4,561.33 | PE29.6x | E7.5% | 4.8% | ||
| 4503Astellas Pharma | JP¥2,014.50 | 0.7% | 12.2% | JP¥3.7t | JP¥2,600.00 | PE31.1x | E17.2% | 3.0% | ||
| 4578Otsuka Holdings | JP¥4,619.00 | 0.7% | -0.5% | JP¥2.5t | JP¥4,809.09 | PE24.1x | E3.9% | 2.2% | ||
| 4507Shionogi | JP¥6,862.00 | 1.3% | 5.5% | JP¥2.1t | JP¥8,010.83 | PE17.7x | E1.7% | 1.7% | ||
| 4151Kyowa Kirin | JP¥3,120.00 | 2.5% | -11.0% | JP¥1.7t | JP¥3,624.55 | PE26.9x | E11.2% | 1.5% | ||
| 4528Ono Pharmaceutical | JP¥3,364.00 | 1.1% | 34.6% | JP¥1.6t | JP¥3,715.00 | PE19.1x | E2.9% | 2.0% |
Page 1 of 1